Great Waters Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$611K Sell
25,379
-134
-0.5% -$3.5K 0.06% 63
2026
Q1
$716K Sell
25,513
-12
-0% -$319 0.08% 50
2025
Q4
$636K Sell
25,525
-95
-0.4% -$2.4K 0.07% 56
2025
Q3
$653K Buy
25,620
+5
+0% +$123 0.08% 50
2025
Q2
$621K Sell
25,615
-1,845
-7% -$43K 0.08% 52
2025
Q1
$696K Buy
27,460
+42
+0.2% +$1.1K 0.1% 50
2024
Q4
$727K Sell
27,418
-308
-1% -$8.35K 0.09% 53
2024
Q3
$802K Buy
27,726
+317
+1% +$9.25K 0.11% 52
2024
Q2
$767K Buy
27,409
+440
+2% +$12.1K 0.12% 49
2024
Q1
$748K Buy
26,969
+868
+3% +$24.1K 0.12% 50
2023
Q4
$776K Buy
26,101
+21
+0.1% +$635 0.14% 48
2023
Q3
$864K Buy
26,080
+316
+1% +$11.2K 0.17% 44
2023
Q2
$945K Buy
25,764
+2
+0% +$78 0.19% 43
2023
Q1
$1.04M Buy
25,762
+3
+0% +$130 0.22% 40
2022
Q4
$1.16M Buy
+25,759
New +$1.23M 0.25% 38

Other funds holding PFE

Great Waters Wealth Management's PFE Position: Q2 2026 in Review

Great Waters Wealth Management reduced its Pfizer (PFE) stake by 0.53% in Q2 2026, selling an estimated $3.5K and leaving 25,379 shares worth $611K. The position accounts for 0.06% of the portfolio, ranked #63.

Great Waters Wealth Management first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.16M in Q4 2022. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Great Waters Wealth Management held 25,379 shares of Pfizer worth $611K as of Q2 2026.
  • Great Waters Wealth Management sold 134 Pfizer shares in Q2 2026, an estimated $3.5K.
  • Pfizer made up 0.06% of Great Waters Wealth Management's portfolio in Q2 2026, its #63 holding.
  • Great Waters Wealth Management first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Great Waters Wealth Management's Pfizer position peaked at $1.16M in Q4 2022.
  • 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Great Waters Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.